Atlas Trials

Beta-glucan and Immune Response to Influenza Vaccine

Clinical trial NCT05074303 · COMPLETED

Trial details

NCT number
NCT05074303
Sponsor
University of Florida
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Healthy Aging
Start date
2022-07-18
Primary completion
2024-03-01
Enrollment
78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.